Information for "CostEffectiveness Evaluation of Remdesivir Therapy inside COVID19 People Necessitating LowFlow Fresh air Remedy Payer Viewpoint throughout Bulgaria"

From EECH Central
Jump to: navigation, search

Basic information

Display titleCostEffectiveness Evaluation of Remdesivir Therapy inside COVID19 People Necessitating LowFlow Fresh air Remedy Payer Viewpoint throughout Bulgaria
Default sort keyCostEffectiveness Evaluation of Remdesivir Therapy inside COVID19 People Necessitating LowFlow Fresh air Remedy Payer Viewpoint throughout Bulgaria
Page length (in bytes)3,465
Page ID1354573
Page content languageEnglish (en)
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)

Edit history

Page creatorSmellfinger0 (Talk | contribs)
Date of page creation10:42, 10 April 2024
Latest editorSmellfinger0 (Talk | contribs)
Date of latest edit10:42, 10 April 2024
Total number of edits1
Total number of distinct authors1
Recent number of edits (within past 90 days)1
Recent number of distinct authors1